Spain will reduce the current doses of the monkey vaccine due to lack of stock and the growth in the number of cases. The Public Health Commission has decided that five will be taken from each current dose. “In people over 18 years of age for whom this vaccine is indicated, a dose of 0.1 milliliter intradermal (both pre-exposure and post-exposure) will be administered except in pregnant women and immunosuppressed who will be administered a dose of 0.5 milliliters per skin route,” they explain.
, the Danish company that owns the vaccine against monkeypox, cannot cope with the production of its serum due to the escalation of cases of this disease worldwide. Given this reality, the company itself assures that it is looking for partners to help it scale manufacturing, according to Bloomberg.
The search could be both in the United States and in Europe and a technology transfer would be handled, a process that is not done from one day to the next, but usually takes several weeks or months, as has been verified with the companies that they have done their own with the vaccines for Covid.
According to data from the consulting firm Airfinity, since May 1.1 million doses have been sent to the United States, 40,000 to Germany, 54,000 to the United Kingdom and the European Commission made a centralized purchase of 50,000 doses.
Of the latter, the Government of Spain has received a total of 17,000 vaccines until yesterday after the arrival on Monday of a new shipment of 5,000 doses. Given the scarcity of serum, in Spain it has been recommended to take more doses from each vial and use prepared syringes so as not to waste anything.